Credentials

PM Holding companies encompass the entire value chain that supports the Life Science companies to improve patients’ engagement and user experience through technology, data and streamlined processes.

We have outstanding achievements and experience in clinical trials from feasibility to submission, therapeutics development supported by innovative technologies, enabling data-driven management across the workflows involving Pharmacovigilance, achieving operational excellence via digital transformation and optimization, besides leveraging the competence of customers by consultancy and training services.

PM Holding companies offer fascinating career opportunities in Life Science for professionals and talents having a growth mindset and enjoying the diversity in a vibrant culture.

Arithmos is a PM Holding company of Business and Technology experts in the Life Science industry.

Arithmos helps companies to gain the best business value through technology-enabled solutions and, through the seQure business unit, Regulatory Compliance and Consulting services.

Arithmos’ team helps Life Sciences companies to identify the right technology solution and managed services model that fits their needs in the best way including assessing the existing processes, technology and infrastructure to carry out possible optimization scenarios.

We support companies with the process re-engineering to leverage the technology engagement capacity of your organization.

With end-to-end managed services for Pharmacovigilance and Quality Assurance embracing GMP, GVP, GCP and GLP areas, we assure companies are operating with fully compliant and reliable processes.

We deliver solutions and services for:

We deliver solutions and services for:

Industry-leading experts combine the knowledge of processes and technologies to implement companies’ digital strategy, enable rapidly scale-up along with fulfilling oversight, governance, and compliance requirements.

We support your:

Est. 2010

seQure is the business unit of Arithmos, related to Regulatory Compliance and Consulting Services.

seQure provides Pharmacovigilance services to customers to support their Pharmacovigilance processes and ensure business continuity.

With a quality-driven culture and customer-oriented service management approach, seQure offers advanced solutions for Quality and Compliance in all GxP areas (GMP, GLP, GVP, GCP).

For the Computer System Validation needs of our customers, seQure offers two levels of services: Strategic Support Model and Consultancy Model.

seQure’s Regulatory Affairs experts support you through all stages of the drug development.

seQure offers Business Consultancy Services for:

seQure provides advanced personalised solutions for Quality and Compliance in GxP areas and supports its customers in designing the most effective system to meet regulatory requirements, reach their goals and improve their processes.

seQure guarantees a complete portfolio of pharmacovigilance services provided by a Team that boasts more than 25 years of experience.

seQure supports the customers in planning, conducting, reviewing, and maintaining the validation status of their applications through GxP assessment, validation planning, user requirement analysis and authoring as well as IQ/OQ/PQ authoring and execution including validation reports.

seQure supports the customers through all stages of drug development and product life cycle.

Est. 2014

CROS NT was founded by Paolo Morelli, and under his leadership the company became a global scaled CRO (Contract Research Organization) with offices in Italy, the UK, and the US, creating an outstanding difference in developing therapeutics for patients among more than 500 projects accomplished with success.

In June 2021, Alira Health, a leading international healthcare and life sciences advisory services firm, acquired CROS NT. 

This thrilling acquisition was a pivotal step for CROS NT, to contribute to Alira Health’s mission of healthcare transformation, creating value for patients. CROS NT brought global biometrics capabilities to Alira Health’s Regulatory, Clinical and Real-World Evidence (RWE) practices.

Paolo Morelli is still in Alira Health’s leadership team as the Executive Vice President, Biometrics. He is leading the growth of Alira Health’s Data Science services.

Joint Ventures

PM Holding owns other investments in companies and initiatives oriented in:

Meet our Team